U.S. Regulators Warn Eli Lilly for Lapses at API Facility

14:26 PM | March 2, 2010 | Deepti Ramesh

The U.S. FDA has issued a warning letter to Eli Lilly’s active pharmaceutical ingredients (API) facility at Carolina, Puerto Rico, for a significant deviation from the current good manufacturing...